Hikma Plans Turkey, Mideast, Africa Acquisitions For Up To $600 Million
This article was originally published in PharmAsia News
Executive Summary
Jordan's Hikma Pharmaceuticals has plans to broaden its global reach beyond Middle East, particularly in Turkey and Egypt and elsewhere in Africa, and has $600 million it could use to acquire other companies, a senior executive said.